Intellectual Property Law

ACI Pharma/Biotech IP Due Diligence Conference
American Conference Institute (ACI) will be holding its 6th National Conference on Pharma/Biotech IP Due Diligence from January 28-29, 2009 in New York. The conference will allow attendees to: ? Define the company's business goals before you begin a due diligence review;? Navigate the dynamic labyrinth of cases that can impact the company's IP rights;? Ensure a data trail that tracks the disclosure of appropriate information;? Gauge the effect of the patents in question on the company's freedom to operate;? Cultivate a sufficient search strategy to enhance your knowledge base of the IP's strengths, weaknesses, and potential;? Evaluate the benefits,...

C5 Pharma/Biotech IP Due Diligence Conference
C5 (UK) will be holding its Pharma/Biotech IP Due Diligence conference on October 28-29, 2008 in Amsterdam, Netherlands. The conference will offer presentations on the following topics: ? Current trends in patent reform and how they impact your due diligence; ? Assessing the level of due diligence required and special considerations for complex multi-jurisdictional and multi-party transactions; ? A practical look at drafting the checklist and due diligence team selection; ? Essential valuation issues affecting the diligence review; ? Finding the target's prior licensing, contractual, and third party obligations; ? Freedom to operate: Ensuring the purchaser/licensee has right to commercialize...

ACI Pharma/Biotech Collaborative Agreements Conference

Biotech/Pharma Lobbying Scoreboard - Part II
By Donald Zuhn -- For the past few months, Patent Docs has been following and reporting on biotech and pharma lobbying efforts. Our interest in this topic stems from the push by Congress over the past year to pass patent reform and follow-on biologics legislation, and corresponding efforts by corporations and organizations during that time to lobby on this legislation...

Biotech/Pharma Lobbying Scoreboard - Second Quarter Update
By Donald Zuhn -- Regular Patent Docs readers have likely noticed that we have been paying close attention to the lobbying efforts of various players in the biotech/pharma industry...

USPTO's Bruce Kisliuk Addresses ACI Conference
By Donald Zuhn -- At last week's American Conference Institute (ACI) Pharma/Biotech Patent Claim Drafting and Prosecution conference, Bruce Kisliuk, the Director of the U.S. Patent and Trademark Office's Technology Center 1600, gave an interesting address in which he touched on a number of topics, and then opened the floor...

Dumb New York Laws
Stupid Laws in the Empire State

New York Building Codes
Building and constructions laws in New York

Selection of State Supreme Court Judges
How State Court Judges are Selected

New York Employment Law
alleged violations of New York employment law.

Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.

Hormone Replacement Therapy Lawsuits See Multi-Million Dollar Settlements
HRT Lawsuits Pharma Faces Multi Million Dollar Settlements

Aetna Settles with New York State for $20 Million

Oppenheimer ATM-Free New York Municipals
401(k) / ERISA Stock Fraud

Racketeering Class Action Filed on Behalf of Foreclosed New York State Homeowners
Racketeering Class Action Filed on Behalf of Foreclosed New York State Homeowners